Cargando…

Efficacy of Roflumilast in Bronchiectasis Patients with Frequent Exacerbations: A Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial

BACKGROUND: Bronchiectasis patients with neutrophilic airway inflammation develop symptoms of chronic cough, sputum production, and recurrent exacerbations. Roflumilast has anti-inflammatory actions via decreased neutrophilic airway inflammation. The effectiveness of roflumilast to reduce bronchiect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juthong, Siwasak, Panyarath, Pattaraporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743631/ https://www.ncbi.nlm.nih.gov/pubmed/34343424 http://dx.doi.org/10.4046/trd.2021.0051

Ejemplares similares

Association between blood eosinophils with exacerbation and patient-reported outcomes in chronic obstructive pulmonary disease patients in an endemic area for parasitic infections: a prospective study
por: Juthong, Siwasak, et al.
Publicado: (2020)

Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)

Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial
por: Baughman, Robert P, et al.
Publicado: (2021)

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis
por: Morton, Miranda, et al.
Publicado: (2023)

Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial
por: Chalmers, James D., et al.
Publicado: (2019)

Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
por: Goyal, Vikas, et al.
Publicado: (2019)

Exacerbation of Bronchiectasis
por: Polverino, Eva, et al.
Publicado: (2017)

Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study
por: Kim, So Rae, et al.
Publicado: (2023)

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial
por: Zirwas, Matthew J., et al.
Publicado: (2023)

A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation
por: Zubairi, Ali Bin Sarwar, et al.
Publicado: (2013)

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
por: Fukuchi, Yoshinosuke, et al.
Publicado: (2016)

The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial
por: Hua, Wei, et al.
Publicado: (2015)

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial
por: Chang, Anne B, et al.
Publicado: (2012)

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations
por: Cowan, Juthaporn, et al.
Publicado: (2018)

The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial
por: Sanjari, Mojgan, et al.
Publicado: (2016)

Efficacy and Safety of Taeeumjowi-tang in Obese Korean Adults: A Double-Blind, Randomized, and Placebo-Controlled Pilot Trial
por: Park, Sunju, et al.
Publicado: (2013)

Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial
por: Cheon, Chunhoo, et al.
Publicado: (2017)

Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage
por: Woo, Peter Y. M., et al.
Publicado: (2020)

Efficacy of Phellinus linteus extract on immunity enhancement: A CONSORT-randomized, double-blind, placebo-controlled pilot trial
por: Ku, Yong Ho, et al.
Publicado: (2022)

Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial
por: Panigrahi, Antarmayee, et al.
Publicado: (2023)

Efficacy and Safety of Roflumilast in Korean Patients with COPD
por: Lee, Jae Seung, et al.
Publicado: (2016)

Chest pain and exacerbations of bronchiectasis
por: King, Paul T, et al.
Publicado: (2012)

The Effects of Bronchiectasis on Asthma Exacerbation
por: Kang, Hye Ran, et al.
Publicado: (2014)

Exacerbations in COPD Patients with Bronchiectasis
por: Minov, Jordan, et al.
Publicado: (2017)

The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019)

Exacerbation Prevention and Management of Bronchiectasis
por: Choi, Joon Young
Publicado: (2023)

Randomized, double-blinded, placebo-controlled pilot study: efficacy of faecal microbiota transplantation on chronic fatigue syndrome
por: Salonen, Tapani, et al.
Publicado: (2023)

The Potential of Double Blinding with Two Placebo Acupuncture Needles: A Randomized Controlled Pilot-Trial
por: Takayama, Miho, et al.
Publicado: (2014)

Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
por: Sonbolestan, Seyed Ali, et al.
Publicado: (2013)

Corrigendum to “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial”
por: Cheon, Chunhoo, et al.
Publicado: (2018)

Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial
por: Shin, Hee-Yeon, et al.
Publicado: (2021)

Efficacy of Liriope platyphylla extract on improving respiratory function: A CONSORT-randomized, double-blind, placebo-controlled pilot trial
por: Won, Eun Sol, et al.
Publicado: (2022)

A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD
por: Cowan, Juthaporn, et al.
Publicado: (2021)

A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease
por: Shafuddin, Eskandarain, et al.
Publicado: (2015)

Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)
por: Gyldenløve, Mette, et al.
Publicado: (2023)

Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations
por: Field, Stephen K.
Publicado: (2011)

Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial
por: Qi, Qian, et al.
Publicado: (2019)

Randomized, Placebo-Controlled, Double-Blind Pilot Study of D-Cycloserine in Chronic Stroke
por: Butler, Andrew J., et al.
Publicado: (2015)

Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study
por: Kinoshita, Toshihiko, et al.
Publicado: (2016)

The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
por: Terpstra, L.C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aq355rglgckprt9upaseqe2fpg